Full Text View
Tabular View
No Study Results Posted
Related Studies
The Use of Anti-CD4 Monoclonal Antibody (mAb)-Fragment for the Imaging of Chronic Inflammation in Patients With Active Rheumatoid Arthritis
This study has been completed.
Study NCT00372177   Information provided by Biotectid GmbH
First Received: September 5, 2006   Last Updated: May 26, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Rheumatoid Arthritis
Polyarthritis
Rheumatism
Autoimmune Disease
Inflammation
Additional conditions recognized in this trial
Arthritis
Arthritis, Rheumatoid
Autoimmune Diseases
Rheumatic Diseases
More general conditions related to this trial
Connective Tissue Diseases
Immune System Diseases
Joint Diseases
Musculoskeletal Diseases
Pathologic Processes
Interventions listed in this trial
Fab-fragment of Anti-human CD4
Additional drug interventions recognized in this trial
Antibodies, Monoclonal
Immunoglobulin Fab Fragments
More general drug interventions related to this trial
Immunologic Factors
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Biotectid GmbH
Dresden University of Technology
University of Leipzig


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services